Which of the following statements is true for buprenorphine?

• A. It is widely used in research animals.
• B. It has a comparatively long duration of action.
• C. It is safe for use in a wide variety of species.
• D. All of the above

Answer: (D)

Buprenorphine is chosen in lab settings because it provides effective analgesia with a favorable safety profile. It acts as a partial agonist at the mu opioid receptor and binds with high affinity, dissociating slowly. This gives strong pain relief while maintaining a ceiling effect for respiratory depression, which adds a margin of safety.

Because of its high receptor affinity and slow dissociation, buprenorphine delivers a longer-lasting analgesic effect compared with many other opioids. In practice, this means fewer injections and more stable pain control for procedures and post‑operative care, often lasting roughly a half-day or longer depending on the species and formulation.

These properties help explain why it is widely used across research animals. Its combination of potent analgesia, extended duration, and relatively forgiving safety profile makes it a versatile option for many species commonly used in laboratory work. While dosing must be tailored to the species and individual, and some species may respond differently, the overall picture is that buprenorphine is widely used, long-acting, and generally safe across a broad range of laboratory species.